[144] Inspire Medical Systems, Inc. SEC Filing
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice relating to proposed resale of restricted common stock that vested under a registered plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice relating to proposed resale of restricted common stock that vested under a registered plan. The filing lists specific vested lots: 571 shares on 02/09/2026, 1,105 shares on 02/13/2026, and 965 shares on 02/20/2026, each described as "restricted stock vesting under a registered plan."
The filing also reports a sale by John Rondoni of 700 shares on 05/14/2026 with an amount shown of $30,106.02 in the "Securities Sold During The Past 3 Months" section.
Insights
Form 144 records proposed resale of vested restricted shares and a recent small sale.
The filing lists multiple lots of restricted stock vesting under a registered plan with vest dates 02/09/2026, 02/13/2026, and 02/20/2026
Cash flow detail for the reported sale is limited to the single line showing $30,106.02 tied to 700 shares sold on 05/14/2026. Timing and distribution mechanics for any proposed resale are not elaborated in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
restricted stock vesting under a registered plan financial
Securities Sold During The Past 3 Months regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.